Immunoprotein Diagnostic Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for immunoprotein diagnostic testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global immunoprotein diagnostic testing market from 2025 to 2032.
Key Insights:
Immunoprotein Diagnostic Testing Market Size (2025E): USD 3.4 Billion
Projected Market Value (2032F): USD 6.4 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 7.2%
Immunoprotein Diagnostic Testing Market - Report Scope:
Immunoprotein diagnostic testing involves the detection of specific proteins in biological samples using immune-based methods such as immunoassays and immunofluorescence techniques. These tests are crucial for the diagnosis and monitoring of a wide range of diseases, including infections, autoimmune disorders, cancers, and metabolic conditions. The market for immunoprotein diagnostic testing is growing due to advancements in testing technologies, increasing demand for early disease diagnosis, and the rising prevalence of chronic and infectious diseases.
Market growth is driven by the increasing need for precise, reliable, and rapid diagnostic tools in clinical settings, particularly for the detection of biomarkers associated with specific health conditions. As the healthcare landscape continues to evolve with an emphasis on personalized medicine, immunoprotein diagnostic tests are playing an essential role in disease detection, management, and treatment optimization.
Market Growth Drivers:
The global immunoprotein diagnostic testing market is propelled by several factors, including the growing demand for early diagnosis and the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. Immunoprotein tests are widely used to detect specific proteins that serve as biomarkers for various diseases, enabling healthcare professionals to make informed decisions about patient treatment plans.
Technological advancements in diagnostic testing, such as the development of high-sensitivity and high-throughput immunoassays, are further driving the market's growth. The increasing adoption of point-of-care diagnostic testing devices, which allow for faster and more efficient testing outside of traditional laboratory settings, is also fueling demand for immunoprotein diagnostic tests.
Moreover, the expansion of personalized medicine and the growing focus on precision healthcare are contributing to the rising demand for immunoprotein diagnostics, as these tests provide detailed insights into disease mechanisms and treatment responses.
Market Restraints:
Despite its promising growth, the immunoprotein diagnostic testing market faces challenges such as high costs associated with advanced testing technologies. The high price of some immunoprotein tests, especially for specialized assays and high-precision instruments, could limit their adoption, particularly in emerging markets with limited healthcare budgets.
Furthermore, there are regulatory hurdles and approval processes that manufacturers of immunoprotein diagnostic tests must navigate, which can delay the availability of new products. Additionally, some diagnostic tests may suffer from issues related to false positives or negatives, impacting their reliability and reducing clinician confidence in certain applications.
Market Opportunities:
The immunoprotein diagnostic testing market presents several opportunities for growth. The increasing focus on personalized and precision medicine offers significant potential for immunoprotein tests, as these diagnostics are key to tailoring treatment plans to individual patients based on their specific biomarkers.
The rapid expansion of healthcare infrastructure in emerging markets, such as Asia Pacific and Latin America, is another key opportunity. As these regions continue to improve their healthcare systems, there will be an increasing demand for advanced diagnostic tools, including immunoprotein testing technologies.
Additionally, the growing trend of home-based diagnostics and the increasing adoption of telemedicine platforms provide new avenues for immunoprotein diagnostic testing. Point-of-care tests and at-home diagnostic kits that utilize immunoprotein biomarkers can significantly increase patient access to essential healthcare services.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the immunoprotein diagnostic testing market globally?
Which regions are seeing the highest demand for immunoprotein diagnostic tests?
How are technological advancements influencing the competitive landscape of the immunoprotein diagnostic testing market?
Who are the key players contributing to the immunoprotein diagnostic testing market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global immunoprotein diagnostic testing market?
Competitive Intelligence and Business Strategy:
Additionally, companies are increasingly offering integrated diagnostic solutions that combine multiple biomarkers to improve diagnostic accuracy and clinical decision-making. The increasing use of automation and artificial intelligence (AI) in immunoprotein testing devices is transforming the market by enabling faster and more reliable testing.
Key Companies Profiled:
Agilent Technologies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Aurora Biomed Inc.
Tecan Trading AG
Promega Corporation
Charles River Laboratories
Creative Biolabs, Others
Immunoprotein Diagnostic Testing Market Research Segmentation:
The immunoprotein diagnostic testing market encompasses a range of products, applications, and technologies.
By Test Type
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Pre-albumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
Others
By Application
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
Others
By Technology
Radioimmunoassay
Immunoturbidity Assay
Immunoprotein Electrophoresis
Enzyme-linked Immunosorbent Assay
Others
By Region
North America
Europe
East Asia
South Asia and Oceania
Latin America
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
Immunoprotein Diagnostic Testing Market Size (2025E): USD 3.4 Billion
Projected Market Value (2032F): USD 6.4 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 7.2%
Immunoprotein Diagnostic Testing Market - Report Scope:
Immunoprotein diagnostic testing involves the detection of specific proteins in biological samples using immune-based methods such as immunoassays and immunofluorescence techniques. These tests are crucial for the diagnosis and monitoring of a wide range of diseases, including infections, autoimmune disorders, cancers, and metabolic conditions. The market for immunoprotein diagnostic testing is growing due to advancements in testing technologies, increasing demand for early disease diagnosis, and the rising prevalence of chronic and infectious diseases.
Market growth is driven by the increasing need for precise, reliable, and rapid diagnostic tools in clinical settings, particularly for the detection of biomarkers associated with specific health conditions. As the healthcare landscape continues to evolve with an emphasis on personalized medicine, immunoprotein diagnostic tests are playing an essential role in disease detection, management, and treatment optimization.
Market Growth Drivers:
The global immunoprotein diagnostic testing market is propelled by several factors, including the growing demand for early diagnosis and the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. Immunoprotein tests are widely used to detect specific proteins that serve as biomarkers for various diseases, enabling healthcare professionals to make informed decisions about patient treatment plans.
Technological advancements in diagnostic testing, such as the development of high-sensitivity and high-throughput immunoassays, are further driving the market's growth. The increasing adoption of point-of-care diagnostic testing devices, which allow for faster and more efficient testing outside of traditional laboratory settings, is also fueling demand for immunoprotein diagnostic tests.
Moreover, the expansion of personalized medicine and the growing focus on precision healthcare are contributing to the rising demand for immunoprotein diagnostics, as these tests provide detailed insights into disease mechanisms and treatment responses.
Market Restraints:
Despite its promising growth, the immunoprotein diagnostic testing market faces challenges such as high costs associated with advanced testing technologies. The high price of some immunoprotein tests, especially for specialized assays and high-precision instruments, could limit their adoption, particularly in emerging markets with limited healthcare budgets.
Furthermore, there are regulatory hurdles and approval processes that manufacturers of immunoprotein diagnostic tests must navigate, which can delay the availability of new products. Additionally, some diagnostic tests may suffer from issues related to false positives or negatives, impacting their reliability and reducing clinician confidence in certain applications.
Market Opportunities:
The immunoprotein diagnostic testing market presents several opportunities for growth. The increasing focus on personalized and precision medicine offers significant potential for immunoprotein tests, as these diagnostics are key to tailoring treatment plans to individual patients based on their specific biomarkers.
The rapid expansion of healthcare infrastructure in emerging markets, such as Asia Pacific and Latin America, is another key opportunity. As these regions continue to improve their healthcare systems, there will be an increasing demand for advanced diagnostic tools, including immunoprotein testing technologies.
Additionally, the growing trend of home-based diagnostics and the increasing adoption of telemedicine platforms provide new avenues for immunoprotein diagnostic testing. Point-of-care tests and at-home diagnostic kits that utilize immunoprotein biomarkers can significantly increase patient access to essential healthcare services.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the immunoprotein diagnostic testing market globally?
Which regions are seeing the highest demand for immunoprotein diagnostic tests?
How are technological advancements influencing the competitive landscape of the immunoprotein diagnostic testing market?
Who are the key players contributing to the immunoprotein diagnostic testing market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global immunoprotein diagnostic testing market?
Competitive Intelligence and Business Strategy:
Additionally, companies are increasingly offering integrated diagnostic solutions that combine multiple biomarkers to improve diagnostic accuracy and clinical decision-making. The increasing use of automation and artificial intelligence (AI) in immunoprotein testing devices is transforming the market by enabling faster and more reliable testing.
Key Companies Profiled:
Agilent Technologies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Aurora Biomed Inc.
Tecan Trading AG
Promega Corporation
Charles River Laboratories
Creative Biolabs, Others
Immunoprotein Diagnostic Testing Market Research Segmentation:
The immunoprotein diagnostic testing market encompasses a range of products, applications, and technologies.
By Test Type
C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Pre-albumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobulin Diagnostic Test
Free Light Chain Diagnostic Test
Others
By Application
Autoimmune Testing
Infectious Disease Testing
Allergy Testing
Endocrine Testing
Oncology Testing
Toxicology Testing
Others
By Technology
Radioimmunoassay
Immunoturbidity Assay
Immunoprotein Electrophoresis
Enzyme-linked Immunosorbent Assay
Others
By Region
North America
Europe
East Asia
South Asia and Oceania
Latin America
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
189 Pages
- 1. Executive Summary
- 1.1. Global Immunoprotein Diagnostic Testing Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. COVID-19 Impact Analysis
- 2.4. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Value Chain Analysis
- 3.2. Key Market Players
- 3.3. Regulatory Landscape
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 3.6. Consumer Behavior Analysis
- 4. Price Trend Analysis, 2019 - 2032
- 4.1. Key Factors Impacting Test Prices
- 4.2. Pricing Analysis, By Test Type
- 4.3. Regional Prices and Test Preferences
- 5. Global Immunoprotein Diagnostic Testing Market Outlook
- 5.1. Market Size (US$ Bn) Analysis and Forecast
- 5.1.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 5.1.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 5.2. Global Immunoprotein Diagnostic Testing Market Outlook: Test Type
- 5.2.1. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019-2024
- 5.2.2. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 5.2.2.1. C-reactive Protein Diagnostic Test
- 5.2.2.2. Complement System Protein Diagnostic Test
- 5.2.2.3. Pre-albumin Diagnostic Test
- 5.2.2.4. Haptoglobin Diagnostic Test
- 5.2.2.5. Immunoglobulin Diagnostic Test
- 5.2.2.6. Free Light Chain Diagnostic Test
- 5.2.2.7. Others
- 5.2.3. Market Attractiveness Analysis: Test Type
- 5.3. Global Immunoprotein Diagnostic Testing Market Outlook: Application
- 5.3.1. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 5.3.2. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 5.3.2.1. Autoimmune Testing
- 5.3.2.2. Infectious Disease Testing
- 5.3.2.3. Allergy Testing
- 5.3.2.4. Endocrine Testing
- 5.3.2.5. Oncology Testing
- 5.3.2.6. Toxicology Testing
- 5.3.2.7. Others
- 5.3.3. Market Attractiveness Analysis: Application
- 5.4. Global Immunoprotein Diagnostic Testing Market Outlook: Technology
- 5.4.1. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
- 5.4.2. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 5.4.2.1. Radioimmunoassay
- 5.4.2.2. Immunoturbidity Assay
- 5.4.2.3. Immunoprotein Electrophoresis
- 5.4.2.4. Enzyme-linked immunosorbent assay
- 5.4.2.5. Others
- 5.4.3. Market Attractiveness Analysis: Technology
- 6. Global Immunoprotein Diagnostic Testing Market Outlook: Region
- 6.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 6.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 6.2.1. North America
- 6.2.2. Latin America
- 6.2.3. Europe
- 6.2.4. East Asia
- 6.2.5. South Asia and Oceania
- 6.2.6. Middle East & Africa
- 6.3. Market Attractiveness Analysis: Region
- 7. North America Immunoprotein Diagnostic Testing Market Outlook
- 7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.1.1. By Country
- 7.1.2. By Test Type
- 7.1.3. By Application
- 7.1.4. By Technology
- 7.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.2.1. U.S.
- 7.2.2. Canada
- 7.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 7.3.1. C-reactive Protein Diagnostic Test
- 7.3.2. Complement System Protein Diagnostic Test
- 7.3.3. Pre-albumin Diagnostic Test
- 7.3.4. Haptoglobin Diagnostic Test
- 7.3.5. Immunoglobulin Diagnostic Test
- 7.3.6. Free Light Chain Diagnostic Test
- 7.3.7. Others
- 7.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.4.1. Autoimmune Testing
- 7.4.2. Infectious Disease Testing
- 7.4.3. Allergy Testing
- 7.4.4. Endocrine Testing
- 7.4.5. Oncology Testing
- 7.4.6. Toxicology Testing
- 7.4.7. Others
- 7.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 7.5.1. Radioimmunoassay
- 7.5.2. Immunoturbidity Assay
- 7.5.3. Immunoprotein Electrophoresis
- 7.5.4. Enzyme-linked immunosorbent assay
- 7.5.5. Others
- 7.6. Market Attractiveness Analysis
- 8. Europe Immunoprotein Diagnostic Testing Market Outlook
- 8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.1.1. By Country
- 8.1.2. By Test Type
- 8.1.3. By Application
- 8.1.4. By Technology
- 8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.2.1. Germany
- 8.2.2. France
- 8.2.3. U.K.
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Rest of Europe
- 8.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 8.3.1. C-reactive Protein Diagnostic Test
- 8.3.2. Complement System Protein Diagnostic Test
- 8.3.3. Pre-albumin Diagnostic Test
- 8.3.4. Haptoglobin Diagnostic Test
- 8.3.5. Immunoglobulin Diagnostic Test
- 8.3.6. Free Light Chain Diagnostic Test
- 8.3.7. Others
- 8.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.4.1. Autoimmune Testing
- 8.4.2. Infectious Disease Testing
- 8.4.3. Allergy Testing
- 8.4.4. Endocrine Testing
- 8.4.5. Oncology Testing
- 8.4.6. Toxicology Testing
- 8.4.7. Others
- 8.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 8.5.1. Radioimmunoassay
- 8.5.2. Immunoturbidity Assay
- 8.5.3. Immunoprotein Electrophoresis
- 8.5.4. Enzyme-linked immunosorbent assay
- 8.5.5. Others
- 8.6. Market Attractiveness Analysis
- 9. East Asia Immunoprotein Diagnostic Testing Market Outlook
- 9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.1.1. By Country
- 9.1.2. By Test Type
- 9.1.3. By Application
- 9.1.4. By Technology
- 9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.2.1. China
- 9.2.2. Japan
- 9.2.3. South Korea
- 9.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 9.3.1. C-reactive Protein Diagnostic Test
- 9.3.2. Complement System Protein Diagnostic Test
- 9.3.3. Pre-albumin Diagnostic Test
- 9.3.4. Haptoglobin Diagnostic Test
- 9.3.5. Immunoglobulin Diagnostic Test
- 9.3.6. Free Light Chain Diagnostic Test
- 9.3.7. Others
- 9.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.4.1. Autoimmune Testing
- 9.4.2. Infectious Disease Testing
- 9.4.3. Allergy Testing
- 9.4.4. Endocrine Testing
- 9.4.5. Oncology Testing
- 9.4.6. Toxicology Testing
- 9.4.7. Others
- 9.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 9.5.1. Radioimmunoassay
- 9.5.2. Immunoturbidity Assay
- 9.5.3. Immunoprotein Electrophoresis
- 9.5.4. Enzyme-linked immunosorbent assay
- 9.5.5. Others
- 9.6. Market Attractiveness Analysis
- 10. South Asia & Oceania Immunoprotein Diagnostic Testing Market Outlook
- 10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.1.1. By Country
- 10.1.2. By Test Type
- 10.1.3. By Application
- 10.1.4. By Technology
- 10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.2.1. India
- 10.2.2. Indonesia
- 10.2.3. Thailand
- 10.2.4. Singapore
- 10.2.5. ANZ
- 10.2.6. Rest of South Asia & Oceania
- 10.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 10.3.1. C-reactive Protein Diagnostic Test
- 10.3.2. Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, Free Light Chain Diagnostic Test, Others
- 10.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.4.1. Autoimmune Testing
- 10.4.2. Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, Toxicology Testing, Others
- 10.4.2.1. Fruit Application
- 10.4.2.2. Mint
- 10.4.2.3. Coffee
- 10.4.2.4. Chocolate
- 10.4.2.5. Others
- 10.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 10.5.1. Radioimmunoassay
- 10.5.2. Immunoturbidity Assay
- 10.5.3. Immunoprotein Electrophoresis
- 10.5.4. Enzyme-linked immunosorbent assay
- 10.5.5. Online Retail
- 10.5.6. Others
- 10.6. Market Attractiveness Analysis
- 11. Latin America Immunoprotein Diagnostic Testing Market Outlook
- 11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.1.1. By Country
- 11.1.2. By Test Type
- 11.1.3. By Application
- 11.1.4. By Technology
- 11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.2.1. Brazil
- 11.2.2. Mexico
- 11.2.3. Rest of Latin America
- 11.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 11.3.1. C-reactive Protein Diagnostic Test
- 11.3.2. Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, Free Light Chain Diagnostic Test, Others
- 11.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.4.1. Autoimmune Testing
- 11.4.2. Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, Toxicology Testing, Others
- 11.4.2.1. Fruit Application
- 11.4.2.2. Mint
- 11.4.2.3. Coffee
- 11.4.2.4. Chocolate
- 11.4.2.5. Others
- 11.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 11.5.1. Radioimmunoassay
- 11.5.2. Immunoturbidity Assay
- 11.5.3. Immunoprotein Electrophoresis
- 11.5.4. Enzyme-linked immunosorbent assay
- 11.5.5. Online Retail
- 11.5.6. Others
- 11.6. Market Attractiveness Analysis
- 12. Middle East & Africa Immunoprotein Diagnostic Testing Market Outlook
- 12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 12.1.1. By Country
- 12.1.2. By Test Type
- 12.1.3. By Application
- 12.1.4. By Technology
- 12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.2.1. GCC Countries
- 12.2.2. Egypt
- 12.2.3. South Africa
- 12.2.4. Northern Africa
- 12.2.5. Rest of Middle East & Africa
- 12.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
- 12.3.1. C-reactive Protein Diagnostic Test
- 12.3.2. Complement System Protein Diagnostic Test
- 12.3.3. Pre-albumin Diagnostic Test
- 12.3.4. Haptoglobin Diagnostic Test
- 12.3.5. Immunoglobulin Diagnostic Test
- 12.3.6. Free Light Chain Diagnostic Test
- 12.3.7. Others
- 12.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 12.4.1. Autoimmune Testing
- 12.4.2. Infectious Disease Testing
- 12.4.3. Allergy Testing
- 12.4.4. Endocrine Testing
- 12.4.5. Oncology Testing
- 12.4.6. Toxicology Testing
- 12.4.7. Others
- 12.5. Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 12.5.1. Radioimmunoassay
- 12.5.2. Immunoturbidity Assay
- 12.5.3. Immunoprotein Electrophoresis
- 12.5.4. Enzyme-linked immunosorbent assay
- 12.5.5. Others
- 12.6. Market Attractiveness Analysis
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2024
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Agilent Technologies, Inc.
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Test Type
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Danaher Corporation
- 13.3.3. Thermo Fisher Scientific Inc.
- 13.3.4. PerkinElmer Inc.
- 13.3.5. Bio-Rad Laboratories, Inc.
- 13.3.6. Aurora Biomed Inc.
- 13.3.7. Tecan Trading AG
- 13.3.8. Promega Corporation
- 13.3.9. Charles River Laboratories
- 13.3.10. Creative Biolabs.
- 13.3.11. Others
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
